Previous Story
Shire’s $5.2bn bet on NPS
Posted On 12 Jan 2015
Comment: 0
Once the prey, now the predator, Shire makes its biggest acquisition by buying the US biotechnology company NPS for $5.2bn. Lex’s Oliver Ralph and Robert Armstrong discuss the growing risks mid-sized pharmaceutical groups must take.
Make better investment decisions with Lex
http://www.ft.com/lex
Click here for more Lex videos
http://video.ft.com/Lex
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes